Evidence map›Paper›PMID 29157223›Full record

ArticleBMC geriatrics2017

Tube feeding decreases pneumonia rate in patients with severe dementia: comparison between pre- and post-intervention.

Shintaro Takenoshita, Keiko Kondo, Keiichi Okazaki, Akihiko Hirao, Keiko Takayama, Keisuke Hirayama, Hiroyuki Asaba, Kenji Nakata, Hideki Ishizu, Hiromi Takahashi and 7 more

Open access · goldAbstract read
In one paragraph

Article in BMC geriatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Enteral tube feeding for people with severe dementia.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Cachexia and advanced dementia.Journal of cachexia, sarcopenia and muscle · 2019
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Shintaro TakenoshitaDepartment of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Keiko KondoDepartment of Psychiatry, Sekizen Hospital, Tsuyama, Japan.
Keiichi OkazakiDepartment of Psychiatry, Hayashi Hospital, Okayama, Japan.
Akihiko HiraoDepartment of Psychiatry, Kawada Hospital, Okayama, Japan.
Keiko TakayamaDepartment of Psychiatry, Kibogaoka Hospital, Tsuyama, Japan.
Keisuke HirayamaDepartment of Psychiatry, Momonosato Hospital, Kasaoka, Japan.
Hiroyuki AsabaDepartment of Psychiatry, Kohnan Hospital, Tamano, Japan.
Kenji NakataDepartment of Psychiatry, Taiyo Hills Hospital, Takahashi, Japan.
Hideki IshizuDepartment of Psychiatry, Zikei Hospital, Okayama, Japan.
Hiromi TakahashiDepartment of Psychiatry, Mannari Hospital, Okayama, Japan.
Hanae Nakashima-YasudaDepartment of Psychiatry, Mannari Hospital, Okayama, Japan.
Yasue SakuradaDepartment of Psychiatry, Mannari Hospital, Okayama, Japan.
Kengo FujikawaDepartment of Psychiatry, Kinoko Espoir Hospital, Kasaoka, Japan.
Osamu YokotaDepartment of Psychiatry, Kinoko Espoir Hospital, Kasaoka, Japan.
Norihito YamadaDepartment of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan.
Seishi TeradaDepartment of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama, 700-8558, Japan. terada@okayama-u.ac.jp.
Middle Western Japan-Dementia Study (mid-Dem study)
Okayama University · JPMannari Hospital · JPHayashi Eye Hospital · JPKohnan Hospital · JP

Funding

JSPS KAKENHI 15K09831JSPS KAKENHI 16K10251
6 · The paper itself

Abstract

backgroundIt is widely supposed that there is no benefit, including extended survival and decreased rate of pneumonia, in patients with severe dementia receiving enteral tube feeding (TF). However, there have been few studies comparing the frequency of pneumonia before and after TF in severe dementia.

methodsNine psychiatric hospitals in Okayama Prefecture participated in this retrospective survey. All inpatients fulfilling the entry criteria were evaluated. All subjects suffered from difficulty in oral intake. Attending physicians thought that the patients could not live without long-term artificial nutrition, and they decided whether or not to make use of long-term artificial nutrition from January 1, 2014 to December 31, 2014.

resultsWe evaluated 58 patients including 46 with TF and 12 without. The mean age of all patients was 79.6 ± 9.0 years old. Patients with probable Alzheimer's disease (n = 38) formed the biggest group, and those with vascular dementia the second (n = 14). Median survival times were 23 months among patients with TF and two months among patients without TF. The start of TF decreased the frequency of pneumonia and the use of intravenous antibiotics.

conclusionsTF decreased pneumonia and antibiotic use, even in patients with severe dementia. The results of this study do not necessarily indicate that we should administer TF to patients with severe dementia. We should consider the quality of life of patients carefully before deciding the use or disuse of TF for patients with severe dementia.

Indexed as

AgedAged, 80 and overAlzheimer DiseaseDementia, VascularEnteral NutritionFemaleHumansIncidenceMaleNutritional StatusPneumonia, AspirationQuality of LifeRetrospective StudiesSurvival RateDementiaNasogastric tubePercutaneous endoscopic gastrostomyPneumoniaTube feeding

Identifiers

PMID29157223
PMCPMC5697435
OpenAlexW2769284188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.